| JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 卷:142 |
| The 17,18-epoxyeicosatetraenoic acid-G protein-coupled receptor 40 axis ameliorates contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques | |
| Article | |
| Nagatake, Takahiro1,2  Shiogama, Yumiko3,4  Inoue, Asuka5  Kikuta, Junichi6  Honda, Tetsuya8  Tiwari, Prabha1,2  Kishi, Takayuki5  Yanagisawa, Atsushi6  Isobe, Yosuke9  Matsumoto, Naomi1,2  Shimojou, Michiko1,2  Morimoto, Sakiko1,2  Suzuki, Hidehiko1,2  Hirata, So-ichiro1,2,10  Steneberg, Par11  Edlund, Helena11  Aoki, Junken5  Arita, Makoto9,12,13  Kiyono, Hiroshi14,15,16  Yasutomi, Yasuhiro3,4,17  Ishii, Masaru6  Kabashima, Kenji8  Kunisawa, Jun1,2,7,10,14,15  | |
| [1] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Ctr Vaccine & Adjuvant Res, Lab Vaccine Mat, Ibaraki, Japan | |
| [2] Natl Inst Biomed Innovat Hlth & Nutr NIBIOHN, Lab Gut Environm Syst, Ibaraki, Japan | |
| [3] NIBIOHN, Lab Immunoregulat & Vaccine Res, Tsukuba, Ibaraki, Japan | |
| [4] NIBIOHN, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan | |
| [5] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Biochem, Sendai, Miyagi, Japan | |
| [6] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Suita, Osaka, Japan | |
| [7] Osaka Univ, Grad Sch Dent, Grad Sch Pharmaceut Sci, Grad Sch Med, Suita, Osaka, Japan | |
| [8] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto, Japan | |
| [9] RIKEN Ctr Integrat Med Sci, Lab Metabol, Yokohama, Kanagawa, Japan | |
| [10] Kobe Univ, Grad Sch Med, Dept Microbiol & Immunol, Kobe, Hyogo, Japan | |
| [11] Umea Univ, Umea Ctr Mol Med, Umea, Sweden | |
| [12] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan | |
| [13] Keio Univ, Grad Sch Pharmaceut Sci, Div Physiol Chem & Metab, Minato Ku, Tokyo, Japan | |
| [14] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol, Tokyo, Japan | |
| [15] Univ Tokyo, Inst Med Sci, Int Res & Dev Ctr Mucosal Vaccines, Tokyo, Japan | |
| [16] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan | |
| [17] Mie Univ, Grad Sch Med, Dept Mol & Expt Med, Div Immunoregulat, Tsu, Mie, Japan | |
| 关键词: 17,18-Epoxyeicosatetraenoic acid; G protein-coupled receptor 40; omega 3 fatty acid; contact hypersensitivity; dermatitis; neutrophil; | |
| DOI : 10.1016/j.jaci.2017.09.053 | |
| 来源: Elsevier | |
PDF
|
|
【 摘 要 】
Background: Metabolites of eicosapentaenoic acid exert various physiologic actions. 17,18-Epoxyeicosatetraenoic acid (17,18-EpETE) is a recently identified new class of antiallergic and anti-inflammatory lipid metabolite of eicosapentaenoic acid, but its effects on skin inflammation and the underlying mechanisms remain to be investigated. Objective: We evaluated the effectiveness of 17,18-EpETE for control of contact hypersensitivity in mice and cynomolgus macaques. We further sought to reveal underlying mechanisms by identifying the responsible receptor and cellular target of 17,18-EpETE. Methods: Contact hypersensitivity was induced by topical application of 2,4-dinitrofluorobenzene. Skin inflammation and immune cell populations were analyzed by using flow cytometric, immunohistologic, and quantitative RT-PCR analyses. Neutrophil mobility was examined by means of imaging analysis in vivo and neutrophil culture in vitro. The receptor for 17,18-EpETE was identified by using the TGF-alpha shedding assay, and the receptor's involvement in the anti-inflammatory effects of 17,18-EpETE was examined by using KO mice and specific inhibitor treatment. Results: We found that preventive or therapeutic treatment with 17,18-EpETE ameliorated contact hypersensitivity by inhibiting neutrophil mobility in mice and cynomolgus macaques. 17,18-EpETE was recognized by G protein-coupled receptor (GPR) 40 (also known as free fatty acid receptor 1) and inhibited chemoattractant-induced Rac activation and pseudopod formation in neutrophils. Indeed, the antiallergic inflammatory effect of 17,18-EpETE was abolished in the absence or inhibition of GPR40. Conclusion: 17,18-EpETE inhibits neutrophil mobility through GPR40 activation, which is a potential therapeutic target to control allergic inflammatory diseases.
【 授权许可】
Free
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 10_1016_j_jaci_2017_09_053.pdf | 3123KB |
PDF